Potential importance of B cells in aging and aging-associated neurodegenerative diseases

Semin Immunopathol. 2017 Apr;39(3):283-294. doi: 10.1007/s00281-016-0615-8. Epub 2017 Jan 12.

Abstract

Our understanding of B cells as merely antibody producers is slowly changing. Alone or in concert with antibody, they control outcomes of seemingly different diseases such as cancer, rheumatoid arthritis, diabetes, and multiple sclerosis. While their role in activation of effector immune cells is beneficial in cancer but bad in autoimmune diseases, their immunosuppressive and regulatory subsets (Bregs) inhibit autoimmune and anticancer responses. These pathogenic and suppressive functions are not static and appear to be regulated by the nature and strength of inflammation. Although aging increases inflammation and changes the composition and function of B cells, surprisingly, little is known whether the change affects aging-associated neurodegenerative disease, such as Alzheimer's disease (AD). Here, by analyzing B cells in cancer and autoimmune and neuroinflammatory diseases, we elucidate their potential importance in AD and other aging-associated neuroinflammatory diseases.

Keywords: Alzheimer’s disease; B-cell; Bregs; Neurodegeneration.

Publication types

  • Review
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / immunology*
  • Aging / metabolism*
  • Alzheimer Disease / etiology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Animals
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism*
  • Humans
  • Immunoglobulins / immunology
  • Inflammation / complications
  • Neurodegenerative Diseases / etiology*
  • Neurodegenerative Diseases / metabolism*
  • Neurodegenerative Diseases / pathology

Substances

  • Immunoglobulins